Oct. 8, 2003 — Intermittent ibandronate for prevention of osteoporosis is effective and well tolerated, according to the results of a study published in the October issue of the Annals of Rheumatic ...
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial) Between February 1, 2007, and May 27, 2014, ...
Natco Pharma Ltd has launched Ibandronate Sodium in tablet and injection forms under the brand name of Bandrone. Ibandronate Sodium is used in the treatment of metastatic bone disease and elevated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results